Inovio Pharmaceuticals Inc (NAS:INO)
$ 11.968 -0.822 (-6.43%) Market Cap: 310.10 Mil Enterprise Value: 239.42 Mil PE Ratio: 0 PB Ratio: 2.32 GF Score: 49/100

Q1 2020 Inovio Pharmaceuticals Inc Earnings Call Transcript

May 11, 2020 / 08:30PM GMT
Release Date Price: $142.8 (+9.63%)
Operator

Good day, everybody, and welcome to the Inovio First Quarter 2020 Financial Results Conference Call. (Operator Instructions)

Please note today's event is being recorded.

I would now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please proceed, sir.

Ben Matone
Inovio Pharmaceuticals, Inc. - Director of IR

Thank you, operator, and thank you, everyone, for joining the Inovio First Quarter 2020 Earnings Call. With me today are Dr. J. Joseph Kim, President and CEO; Peter Kies, our Chief Financial Officer; Dr. Prakash Bhuyan, Vice President of Clinical Development and Head of Inovio's Clinical Programs to treat HPV-related precancers; and Dr. Kate Broderick, Senior Vice President of Research and Development and Project Lead for Inovio's infectious disease programs, who together will review our corporate, financial and development progress for the first quarter 2020. Dr. Jacqueline Shea, our Chief Operating Officer, is also with us and will be joining for the Q&A session following prepared remarks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot